COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,620 Articles (22,913 medRxiv, 8,707 bioRxiv)

Most recent first Previous |  Page 762: Articles 7611-7620  | Next

Modeling the USA Late Winter 2021 and Spring 2022 CoVID-19 Resurgences
Eng, G.
10.1101/2022.06.24.22276889 — Posted: 2022-06-27
Population genomic insights into the evolution of the SARS-CoV-2 Omicron variant
Garg, K. M., Lamba, V., Chattopadhyay, B.
10.1101/2022.06.27.22276933 — Posted: 2022-06-27
Within-hotel transmission of SARS-CoV-2 during on-arrival quarantine in Hong Kong
Adam, D. C., Martin-Sanchez, M., Gu, H., Wu, P., Lau, E. H. Y., Leung, G. M., Poon, L. L. M., Cowling, B. J.
10.1101/2022.06.25.22276894 — Posted: 2022-06-27
Capturing the SARS-CoV-2 infection pyramid within the municipality of Rotterdam using longitudinal sewage surveillance
de Graaf, M., Langeveld, J., Post, J., Carrizosa, C., Franz, E., Izquierdo Lara, R. W., Elsinga, G., Heijnen, L., Been, F., van Beek, J., Schilderpoort, R., Vriend, R., Fanoy, E., de Schepper, E. I. T., Koopmans, M. P. G., Medema, G.
10.1101/2022.06.27.22276938 — Posted: 2022-06-27
Non-Adherence of PLWHA in taking Antiretroviral during the COVID-19 pandemic in West Sumatra, Indonesia: Qualitative analysis
suwito, A., ikhwana, I., usman, E., widya murni, A., Hasnita, E., Indra, R.
10.1101/2022.06.26.22276906 — Posted: 2022-06-27
Antiviral T-cell Biofactory platform for SARS-CoV-2
Ssemadaali, M. A., Newmyer, S., Radhakrishnan, H., Arredondo, J., Javitz, H. S., Dandekar, S., Bhatnagar, P.
10.1101/2022.06.26.497669 — Posted: 2022-06-27
Vaccination saves lives: How do patients with chronic diseases and severe COVID-19 fare? Analysis from Indias National Clinical registry for COVID-19
Mukherjee, A., Kumar, G., Turuk, A., Bhalla, A., Bingi, T. C., Bhardwaj, P., Baruah, T. D., Mukherjee, S., Talukdar, A., Ray, Y., John, M., Khambholja, J. R., Patel, A. H., Bhuniya, S., Joshi, R., Menon, G. R., Sahu, D., Rao, V. V., Bhargava, B., Panda, S.
10.1101/2022.06.22.22276744 — Posted: 2022-06-27
Compliant citizens, defiant rebels or neither? Exploring changing COVID-19 vaccine attitudes and decisions in Bradford, UK: Findings from a follow-up qualitative study
Lockyer, B., Moss, R. H., Endacott, C., Islam, S., Sheard, L., Bradford Institute for Health Research Covid-19 Scientific Advisory Group
10.1101/2022.06.24.22276852 — Posted: 2022-06-27
IMMUNE PROFILES TO DISTINGUISH HOSPITALIZED VERSUS AMBULATORY COVID-19 CASES IN OLDER PATIENTS
Klingler, J., Lambert, G. S., Bandres, J. C., Emami-Gorizi, R., Nadas, A., Oguntuyo, K. Y., Amanat, F., PARIS Study Team, , Simon, V., Lee, B., Zolla-Pazner, S., Upadhyay, C., Hioe, C. E.
10.1101/2022.06.23.22276820 — Posted: 2022-06-27
The 2020 U.S. cancer screening deficit and the timing of adults' most recent screen: A population-based quasi-experiment
Semprini, J., Ranganathan, R.
10.1101/2022.06.24.22276836 — Posted: 2022-06-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).